SEC Form 4 · accession 0001209191-15-082349
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Stein
Officer — President & CEO · Director
Period of report
Nov 24, 2015
Accepted (ET)
Nov 27, 2015 · 5:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 24, 2015 | P | 5,400 | $14.97 | A | 5,400 | D | |
| Common Stock | Nov 25, 2015 | P | 1,300 | $15.60 | A | 6,700 | D | |
| Common Stock | holding | — | — | — | 199,387 | I | By trust |
Table II — derivative securities
No Table II lines on this filing.